Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Skin, Basal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05170035
What this trial is testing

Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery

Who this might be right for
Skin CancerBasal Cell Carcinoma
Bispebjerg Hospital 26
Testing effectiveness (Phase 2)Temporarily pausedNCT05929664
What this trial is testing

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Who this might be right for
Locally Advanced Basal Cell CarcinomaBasal Cell Carcinoma
Thomas Jefferson University 70
Not applicableStudy completedNCT00203008
What this trial is testing

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Who this might be right for
Parkinson's DiseaseMalignant Melanoma
Teva Branded Pharmaceutical Products R&D, Inc. 2,106
Testing effectiveness (Phase 2)Ended earlyNCT04410874
What this trial is testing

Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma
Ivan Litvinov 1
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Not applicableUnknownNCT03092830
What this trial is testing

Molecular Characterization of Cutaneous Tumors

Who this might be right for
Squamous Cell CarcinomaBasal Cell Carcinoma
Rabin Medical Center 500
Early research (Phase 1)Study completedNCT01172028
What this trial is testing

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerEsophageal CancerGastric Cancer+4 more
University of Arizona 33
Not applicableStudy completedNCT04229277
What this trial is testing

Fast Track Diagnosis of Skin Cancer by Advanced Imaging

Who this might be right for
Malignant MelanomaNevus, PigmentedBasal Cell Carcinoma+1 more
University Hospital Bispebjerg and Frederiksberg 41
Not applicableStudy completedNCT01508013
What this trial is testing

An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk

Who this might be right for
Skin Cancer
East Tennessee State University 443
Early research (Phase 1)Study completedNCT03458117
What this trial is testing

T-VEC in Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
University of Zurich 26
Early research (Phase 1)Study completedNCT01637194
What this trial is testing

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Colon Cancer+46 more
Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT04362722
What this trial is testing

Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients

Who this might be right for
Carcinoma, Basal CellCarcinoma, Cutaneous Squamous Cell
Philogen S.p.A. 40
Not applicableStudy completedNCT01482104
What this trial is testing

New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)

Who this might be right for
Skin NeoplasmsCarcinoma, Basal Cell
Norwegian University of Science and Technology 277
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Not applicableStudy completedNCT03509467
What this trial is testing

Using MC1R Genotype to Impact Melanoma Risk Behavior

Who this might be right for
Melanoma (Skin)Squamous Cell CarcinomaSquamous Cell Cancer+3 more
H. Lee Moffitt Cancer Center and Research Institute 2,054
Post-approval studies (Phase 4)Study completedNCT00314756
What this trial is testing

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Who this might be right for
Basal Cell Carcinoma
Wake Forest University 15
Testing effectiveness (Phase 2)Ended earlyNCT02067104
What this trial is testing

Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention

Who this might be right for
Basal Cell Carcinomas
University of Arizona 9
Not applicableStudy completedNCT00809016
What this trial is testing

PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 40
Not applicableStudy completedNCT02296970
What this trial is testing

An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence

Who this might be right for
Basal Cell Carcinoma
University of Pittsburgh 78
Not applicableStudy completedNCT00793169
What this trial is testing

Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma
Northwestern University 19
Next Page